Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Goetz

Showing results (111-120 of 397) with videos related to

Pageof 40
Sort By:
Medical Care|January 1, 1982
Medical information systems: assessing impact in the areas of hypertension, obesity and renal diseaseJ L Rogers, O M Haring, P M Wortman, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|April 2, 2023
Development and validation of a liquid chromatography-mass spectrometry assay for quantification of Z- and E- isomers of endoxifen and its metabolites in plasma from women with estrogen receptor positive breast cancerSarah A Buhrow, Emily J Koubek, Matthew P Goetz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 11, 2025
Endocrine Therapy Omission in Estrogen Receptor-Low (1%-10%) Early-Stage Breast CancerGrace M Choong, Tanya L Hoskin, Judy C Boughey, et al.
Annals of Surgical Oncology|January 6, 2017
Has the Time Come to Stop Surgical Staging of the Axilla for All Women Age 70 Years or Older with Hormone Receptor-Positive Breast Cancer?Judy C Boughey, Bruce G Haffty, Elizabeth B Habermann, et al.
The Journal of Chemical Physics|June 10, 2017
Electron-phonon coupling in anthracene-pyromellitic dianhydrideDerek Vermeulen, Nathan Corbin, Katelyn P Goetz, et al.
Current Opinion in Biotechnology|August 20, 2021
Accelerating vein-to-vein cell therapy workflows with new bioanalytical strategiesGianna T Flint, Patricia R Drake, Joel P Goetz, et al.
Annals of Surgical Oncology|September 12, 2024
In-Breast Tumor Progression During Neoadjuvant Chemotherapy: Impact on and Factors Influencing Distant Recurrence-Free SurvivalKathryn M Eckert, Tanya L Hoskin, Carrie A Olson, et al.
Artificial Organs|February 9, 1999
Biocompatible magnetic polymer carriers for in vivo radionuclide deliveryW Schütt, C Grüttner, J Teller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 19, 2019
Tamoxifen Metabolism and Breast Cancer Recurrence: A Question Unanswered by CYPTAMMatthew P Goetz, Vera J Suman, Yusuke Nakamura, et al.
Cancer Research|February 27, 2009
The tamoxifen metabolite, endoxifen, is a potent antiestrogen that targets estrogen receptor alpha for degradation in breast cancer cellsXianglin Wu, John R Hawse, Malayannan Subramaniam, et al.
Pageof 40

Showing results (111-120 of 397) with videos related to

Sort By:
Pageof 40
Medical Care|January 1, 1982
Medical information systems: assessing impact in the areas of hypertension, obesity and renal diseaseJ L Rogers, O M Haring, P M Wortman, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|April 2, 2023
Development and validation of a liquid chromatography-mass spectrometry assay for quantification of Z- and E- isomers of endoxifen and its metabolites in plasma from women with estrogen receptor positive breast cancerSarah A Buhrow, Emily J Koubek, Matthew P Goetz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 11, 2025
Endocrine Therapy Omission in Estrogen Receptor-Low (1%-10%) Early-Stage Breast CancerGrace M Choong, Tanya L Hoskin, Judy C Boughey, et al.
Annals of Surgical Oncology|January 6, 2017
Has the Time Come to Stop Surgical Staging of the Axilla for All Women Age 70 Years or Older with Hormone Receptor-Positive Breast Cancer?Judy C Boughey, Bruce G Haffty, Elizabeth B Habermann, et al.
The Journal of Chemical Physics|June 10, 2017
Electron-phonon coupling in anthracene-pyromellitic dianhydrideDerek Vermeulen, Nathan Corbin, Katelyn P Goetz, et al.
Current Opinion in Biotechnology|August 20, 2021
Accelerating vein-to-vein cell therapy workflows with new bioanalytical strategiesGianna T Flint, Patricia R Drake, Joel P Goetz, et al.
Annals of Surgical Oncology|September 12, 2024
In-Breast Tumor Progression During Neoadjuvant Chemotherapy: Impact on and Factors Influencing Distant Recurrence-Free SurvivalKathryn M Eckert, Tanya L Hoskin, Carrie A Olson, et al.
Artificial Organs|February 9, 1999
Biocompatible magnetic polymer carriers for in vivo radionuclide deliveryW Schütt, C Grüttner, J Teller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 19, 2019
Tamoxifen Metabolism and Breast Cancer Recurrence: A Question Unanswered by CYPTAMMatthew P Goetz, Vera J Suman, Yusuke Nakamura, et al.
Cancer Research|February 27, 2009
The tamoxifen metabolite, endoxifen, is a potent antiestrogen that targets estrogen receptor alpha for degradation in breast cancer cellsXianglin Wu, John R Hawse, Malayannan Subramaniam, et al.
Pageof 40